Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.
Jafarnezhad-Ansariha F, Yekaninejad MS, Jamshidi AR, Mansouri R, Vojdanian M, Mahmoudi M, Fattahi MJ, Hashemi SN, Rehm BHA, Matsuo H, Esposito E, Cuzzocrea S, Mirshafiey A. Jafarnezhad-Ansariha F, et al. Among authors: yekaninejad ms. Inflammopharmacology. 2018 Apr;26(2):375-384. doi: 10.1007/s10787-017-0386-4. Epub 2017 Aug 17. Inflammopharmacology. 2018. PMID: 28819782 Clinical Trial.
Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial.
Fattahi MJ, Jamshidi AR, Mahmoudi M, Vojdanian M, Yekaninejad MS, Jafarnezhad-Ansariha F, Ahmadi H, Rehm BHA, Matsuo H, Cuzzocrea S, Hosseini M, Hashemi SN, Aghazadeh Z, Mirshafiey A. Fattahi MJ, et al. Among authors: yekaninejad ms. Int Immunopharmacol. 2018 Jan;54:112-117. doi: 10.1016/j.intimp.2017.11.003. Epub 2017 Nov 8. Int Immunopharmacol. 2018. PMID: 29127910 Clinical Trial.
Combination treatment of docosahexaenoic acid (DHA) and all-trans-retinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis.
Mousavi Nasl-Khameneh A, Mirshafiey A, Naser Moghadasi A, Chahardoli R, Mahmoudi M, Parastouei K, Yekaninejad MS, Saboor-Yaraghi AA. Mousavi Nasl-Khameneh A, et al. Among authors: yekaninejad ms. Neurol Res. 2018 Jan;40(1):11-17. doi: 10.1080/01616412.2017.1382800. Epub 2017 Nov 18. Neurol Res. 2018. PMID: 29155646
Immunotherapeutic Effects of β-D Mannuronic Acid on IL-4, GATA3, IL-17 and RORC Gene Expression in the PBMC of Patients with Inflammatory Bowel Diseases.
Alhassan Mohammed H, Saboor-Yaraghi AA, Vahedi H, Panahi G, Hemmasi G, Yekaninejad MS, Mirshafiey A. Alhassan Mohammed H, et al. Among authors: yekaninejad ms. Iran J Allergy Asthma Immunol. 2018 Aug 12;17(4):308-317. doi: 10.18502/ijaai.v17i4.90. Iran J Allergy Asthma Immunol. 2018. PMID: 30537794 Free article.
The immunomodulatory effects of all-trans retinoic acid and docosahexaenoic acid combination treatment on the expression of IL-2, IL-4, T-bet, and GATA3 genes in PBMCs of multiple sclerosis patients.
Nasl-Khameneh AM, Mirshafiey A, Moghadasi AN, Yekaninejad MS, Parastouei K, Nejati S, Saboor-Yaraghi AA. Nasl-Khameneh AM, et al. Among authors: yekaninejad ms. Neurol Res. 2023 Jun;45(6):510-519. doi: 10.1080/01616412.2022.2162222. Epub 2023 Jan 4. Neurol Res. 2023. PMID: 36598970
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial.
Toroghi N, Abbasian L, Nourian A, Davoudi-Monfared E, Khalili H, Hasannezhad M, Ghiasvand F, Jafari S, Emadi-Kouchak H, Yekaninejad MS. Toroghi N, et al. Among authors: yekaninejad ms. Pharmacol Rep. 2022 Feb;74(1):229-240. doi: 10.1007/s43440-021-00341-0. Epub 2021 Nov 27. Pharmacol Rep. 2022. PMID: 34837648 Free PMC article. Clinical Trial.
249 results